Fmoc-L-Trp(Boc)

We are Fmoc-L-Trp(Boc) CAS:143824-78-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[1-[(2-methylpropan-2-yl)oxycarbonyl]indol-3-yl]propanoic acid
CAS.NO: 143824-78-6
Molecular Formula: C31H30N2O6
Molecular Weight: 526.58000

Synonyms:
N(in)-Boc-Nalpha-Fmoc-L-tryptophan
Fmoc-L-Trp(Boc)
Nα-[(9H-Fluoren-9-ylMethoxy)carbonyl]-N1-tert-butoxycarbonyl-L-tryptophan
L-Tryptophan, 1-[(1,1-dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-
(2S)-3-{1-[(tert-butoxy)carbonyl]-1H-indol-3-yl}-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}propanoic acid
Fmoc-Trp(tert-butyloxycarbonyl)-OH
Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N1-tert-butoxycarbonyl-L-tryptophan
N(in)-Boc-Nα-Fmoc-L-Tryptophan
Nα-Fmoc-N(in)-Boc-L-Tryptophan
N1-Boc-Nα-Fmoc-L-tryptophan
L B656 HHJ H1OVMYVQ1- DT56 BNJ BVOX1&1&1 &&L or S Form
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-tryptophan
Fmoc-L-Trp(Boc)-OH
N-Fmoc-NIn-Boc-L-trp
N-(9-fluorenyl)methoxycarbonyl-Trp(Boc)-OH
Nalpha-Fmoc-N(in)-Boc-L-tryptophan
1-(tert-Butoxycarbonyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tryptophan

Physical and Chemical Properties:
Density: 1.28 g/cm3
Boiling point: /
Melting point: 86 – 90ºC
Flash point:/
Refractive index:1.649

Specification:
Appearance: White to Off-white crystalline powder
Purity:≥99%
Moisture Content: ≤0.2%
Impurity: ≤0.2%
Loss on drying:≤0.50%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at 2-8ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:Fmoc-Trp(Boc)-OH is a very useful synthetic intermediate. It is used to prepare Trp containing-peptides.

Related News: The news, however, was greeted with skepticism online in China, with many — including numerous medical experts — questioning whether the findings were supported by clinical evidence from treating coronavirus patients.7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one The news, however, was greeted with skepticism online in China, with many — including numerous medical experts — questioning whether the findings were supported by clinical evidence from treating coronavirus patients.551-62-2 Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.4-Trifluoromethylbenzoylchloride Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as “bulk pharmaceutical chemicals (BPCs).”